Ayers et al. reported that IFN-γ-associated transcriptional profiles predict the clinical response to PD-1 blockade in melanoma, head and neck squamous cell carcinoma (HNSCC), and gastric cancer [4]. The gene discussed is IFNG; the disease is head and neck squamous cell carcinoma.